ArticleOncoimmunology2015
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.
Ilkka Liikanen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it
ArticleOncoimmunology2015
Ilkka Liikanen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.